Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 04, 2026
Marriott International (MAR) Q2 2026 Earnings: Strong U.S. RevPAR Growth Offset by Revenue Miss

Marriott International (MAR) Q2 2026 Earnings: Strong U.S. RevPAR Growth Offset by Revenue Miss

Key Takeaways

  • Adjusted earnings per share (EPS) of $3.19 surpassed Wall Street consensus estimates of approximately $3.08, reflecting strong operational leverage and fee growth.
  • Total revenue reached $7.07 billion, up 4.8% year-over-year but falling short of analyst forecasts of roughly $7.21 billion, pressured by international headwinds.
  • Global RevPAR (Revenue Per Available Room) rose 3.4%, propelled by a 5.0% surge in the U.S. & Canada, while international RevPAR slipped 0.5%.
  • Middle East RevPAR tumbled 43% as ongoing regional conflict severely disrupted travel demand, dragging down overall international performance.
  • Full-year RevPAR guidance was raised to 3%-3.5% growth, but the company's third-quarter adjusted EPS outlook of $2.74-$2.82 came in below Street expectations.
  • Shares declined 3% to 7% following the August 3 release as investors weighed the revenue miss and cautious near-term profit forecast against otherwise solid operating momentum.

Why These Earnings Matter Now

MAR’s second-quarter 2026 results landed at a pivotal moment for the global hospitality industry. Travel demand in the United States continues to benefit from the FIFA World Cup, peak summer leisure travel, and resilient consumer spending, while international markets face uneven recovery trajectories. For investors, this earnings report serves as a critical barometer of how the world’s largest hotel operator is navigating a tale of two markets — robust domestic strength versus overseas friction. Coming on the heels of similarly mixed updates from peers Hilton (HLT) and Hyatt (H), who also raised full-year room revenue forecasts while flagging Middle East exposure, MAR’s report offers broader signals about the health of global travel, pricing power, and the pace of hotel development in an increasingly complex geopolitical environment.

Breaking Down the Reported Numbers

MAR posted second-quarter 2026 total revenue of $7.07 billion, representing year-over-year growth of 4.8% but missing the Wall Street consensus of roughly $7.21 billion. The top-line shortfall was partially attributed to a $27 million property-related litigation accrual and lower termination fees, which weighed on owned, leased, and other revenue — that segment declined to $49 million from $78 million a year earlier.

On the bottom line, reported net income was $766 million, up marginally from $763 million in the prior-year quarter, translating to reported diluted EPS of $2.90. However, the more closely watched adjusted figures painted a stronger picture: adjusted net income reached $844 million and adjusted diluted EPS came in at $3.19, exceeding analyst estimates of roughly $3.08 by approximately 3.6%. Adjusted EBITDA climbed 13% to $1.59 billion, underscoring the asset-light fee-based model’s earnings power.

Gross fee revenues — a key indicator of the company’s core franchise and management business — rose 13% year-over-year to $1.58 billion, fueled by higher co-branded credit card fees, RevPAR growth, and net room additions. The company added approximately 17,900 net rooms during the quarter, bringing the global system to more than 10,000 properties and nearly 1.81 million rooms. The worldwide development pipeline reached a record of nearly 4,200 properties representing approximately 629,000 rooms, up nearly 7% from the prior year.

Regionally, the performance split was stark. U.S. & Canada RevPAR jumped 5.0% — the strongest quarterly increase in 13 quarters — driven by broad-based demand across chain scales and customer segments, including a more than 9% increase in luxury RevPAR. International RevPAR declined 0.5%, with the EMEA region down over 5%, as a 43% collapse in Middle East RevPAR overwhelmed solid growth in Europe. By contrast, APEC RevPAR rose more than 5% and Greater China RevPAR increased more than 3%.

How the Market Reacted

MAR shares declined between 3% and 7% in the trading session following the August 3 earnings release. The initial sell-off reflected a tug-of-war in investor sentiment: while adjusted EPS comfortably beat expectations and full-year RevPAR guidance was raised, the top-line revenue miss and a weaker-than-expected third-quarter profit forecast soured the immediate reaction. The company guided for Q3 2026 adjusted EPS of $2.74 to $2.82, below the analyst consensus of approximately $2.87, with finance chief Jennifer Mason citing the persistent drag from Middle East operations and a modest foreign-exchange headwind tied to Japanese co-branded credit card fees.

Beneath the headline numbers, investors appeared to weigh the durability of U.S. demand — amplified by the World Cup — against the uncertainty clouding international markets. The fact that MAR raised its full-year RevPAR outlook while simultaneously delivering cautious quarterly profit guidance underscored the cross-currents. The new long-term co-branded credit card agreements with JPMorgan Chase and American Express, expected to eventually add $100 million to $125 million in annual fee revenue by 2028, provided a positive long-term narrative that partially offset near-term concerns.

Forward Outlook and Key Factors to Monitor

MAR enters the second half of 2026 with upgraded full-year expectations but undeniable pockets of pressure. The company now projects global RevPAR growth of 3% to 3.5% for the full year, up from its prior 2% to 3% range, with third-quarter RevPAR growth expected at 3.5% to 4%. Adjusted EBITDA is forecast to rise 11% to 12% to between $5.97 billion and $6.03 billion, while full-year adjusted EPS growth is targeted at 16% to 18%.

However, several factors demand close monitoring. The Middle East conflict remains the single largest wildcard — MAR expects the region to subtract roughly 100 basis points from full-year global RevPAR, an improvement from the prior estimate of 100 to 125 basis points, but fourth-quarter comparisons will be particularly challenging given difficult 2025 comps. Construction delays in the Middle East are also expected to push full-year net room growth toward the low end of the 4.5% to 5% guidance range.

On the positive side, the World Cup’s contribution to global RevPAR was revised upward to approximately 45 basis points — above the prior 30 to 35 basis point estimate — signaling that event-driven demand is exceeding initial expectations. The U.S. midterm elections in November could introduce a modest fourth-quarter headwind, but the underlying demand picture in the company’s largest market remains firmly constructive.

The newly signed co-branded credit card agreements with JPMorgan Chase and American Express represent a meaningful catalyst. With approximately $30 million in incremental fee contributions expected in 2026 and the annual run-rate potentially reaching $100 million to $125 million by 2028, this partnership renewal strengthens the Marriott Bonvoy loyalty ecosystem — which now counts more than 295 million members — and provides a high-margin revenue stream largely insulated from occupancy cycles. Investors should also watch development signings and conversion activity, both of which reached record levels in the first half, signaling sustained owner confidence in the MAR brand portfolio.

Using AI Tools to Analyze Hospitality Stocks

In my own research process, I often turn to Tickeron’s AI Screener to quickly filter hospitality names like MAR against peers using technical patterns, fundamental metrics, and AI signals. It helps me spot relative strength in U.S. RevPAR trends or flag international risks without manually combing through dozens of reports. This kind of targeted screening keeps my analysis efficient when earnings season brings mixed signals across the sector.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MAR

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MAR's RSI Indicator climbs out of oversold territory

The RSI Indicator for MAR moved out of oversold territory on August 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In of the 17 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MAR advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

MAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MAR as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MAR turned negative on August 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

MAR moved below its 50-day moving average on July 30, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MAR crossed bearishly below the 50-day moving average on July 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MAR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MAR entered a downward trend on July 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MAR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (9.646). P/E Ratio (36.706) is within average values for comparable stocks, (42.827). Projected Growth (PEG Ratio) (2.009) is also within normal values, averaging (28.646). Dividend Yield (0.008) settles around the average of (0.020) among similar stocks. P/S Ratio (3.537) is also within normal values, averaging (2.880).

Notable companies

The most notable companies in this group are Marriott International (NASDAQ:MAR), Hilton Worldwide Holdings (NYSE:HLT), H World Group Limited (NASDAQ:HTHT).

Industry description

Companies that operate paid and subscriber-based broadcast facilities for cable and home satellite systems. Comcast Corp, Charter Communications, Inc. and DISH Network Corporation are some of the biggest cable/satellite TV providers. Customers typically pay a regular monthly fee to cable TV operators for unlimited access to a certain package of channels. Since the rising popularity of online streaming services have increased instances of cord-cutting among consumers, several cable operators have also diversified into internet services to milk the burgeoning appetite for internet-based content.

Market Cap

The average market capitalization across the Cable/Satellite TV Industry is 20.85B. The market cap for tickers in the group ranges from 196.44K to 92.46B. MAR holds the highest valuation in this group at 92.46B. The lowest valued company is UOKA at 196.44K.

High and low price notable news

The average weekly price growth across all stocks in the Cable/Satellite TV Industry was -0%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 0%. INTG experienced the highest price growth at 14%, while CHH experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Cable/Satellite TV Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was -38%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 42
Price Growth Rating: 58
SMR Rating: 39
Profit Risk Rating: 65
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
MAR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

an operator of hotels and related lodging facilities

Industry CableSatelliteTV

Profile
Details
Industry
Hotels Or Resorts Or Cruiselines
Address
7750 Wisconsin Avenue
Phone
+1 301 380-3000
Employees
414000
Web
https://www.marriott.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.